Hook / thesis
Bunge is a buy on this pullback. The company sits at the center of several durable demand vectors - population growth, protein consumption, and renewable feedstock demand - and is trading at a valuation that already discounts cyclical softness. With a market cap near $22.1 billion and management now committing capital to shareholders (including a $3 billion buyback), the risk-reward on a disciplined, pullback entry looks attractive.
Put simply: agricultural commodities are not a fad. Bunge's integrated footprint - from origination to processing to global distribution - gives it durable scale advantages. That matters now because short-term margin cycles frequently create buying opportunities for long-run owners.
What Bunge does and why the market should care
Bunge Global SA is an integrated agribusiness and food-ingredients company operating across Agribusiness, Refined & Specialty Oils, Milling, Sugar & Bioenergy, and Corporate functions. The Agribusiness arm handles purchasing, storage, transport and sale of key commodities; Refined & Specialty Oils supplies cooking oils, specialty ingredients and renewable diesel feedstocks; Milling sells flour and bakery inputs. In short, Bunge connects farmers to consumers and industrial users at scale.
Why that matters: demand for food, feed and renewable fuel feedstocks is hardly optional. Macro trends like rising protein consumption (including plant-based proteins), increased biodiesel/renewable diesel feedstock demand, and a global shift toward more processed food in emerging markets underpin long-term volume tails. Recent market reports reinforce that trend: the soy protein concentrate market is projected to grow to $7.13 billion by 2035 and cooking oil recycling for biodiesel is expanding - both areas that intersect Bunge's product set.
Recent data points that support the bull case
- Market capitalization sits around $22.1 billion, with an enterprise value near $36.1 billion and EV/EBITDA roughly 11.9x - a valuation that is reasonable for a global commodity-integrated business with scale advantages and steady cash returns potential.
- Trailing EPS in the most recent ratios is $5.24, putting the stock at a P/E in the low-20s (the snapshot P/E is ~21.6). That is not a frothy multiple for a business with strategic asset-backed positions across the grain and oil value chain.
- Management set an ambitious mid-cycle EPS target of $15 by 2030 at Investor Day (03/10/2026) and authorized $3 billion in share repurchases while committing to return at least 50% of discretionary cash flow to shareholders. Even if full realization is multi-year, the authorization signals a disciplined capital-return orientation.
- Dividend yield is meaningful at about 2.5% (dividend per share $0.72; ex-dividend date 08/18/2026), which helps carry the position while waiting for cyclical recovery.
- Operational highlights: the company reported Q2 2025 Non-GAAP EPS of $1.31 on $12.8 billion of revenue (07/31/2025) while completing the Viterra acquisition and exiting certain non-core assets, which should incrementally simplify operations and improve capital allocation optionality.
Valuation framing
Valuation is pragmatic. The stock trades near $115.11 today (current price) for a market cap around $22.1 billion and an EV of ~$36.1 billion. At a P/E in the low-20s and EV/EBITDA ~11.9x, Bunge sits below many higher-growth packaged-food peers but above pure commodity traders at trough cycles. Consider three anchors:
- Absolute: $115 implies the market is pricing moderate growth and some margin normalization, not a boom. If management's mid-cycle EPS target of $15 materializes, the multiple on mid-cycle EPS would imply upside to current price even with a conservative multiple contraction.
- Relative: As a vertically integrated operator (origination + processing + branded oils), Bunge should command a premium to pure trading houses in tighter markets because of downstream margin capture and sticky customer relationships.
- Balance Sheet: Debt/equity sits near 0.96, and the firm currently shows negative free cash flow (free cash flow -$711M in the ratios snapshot). That argues for measured expectations around near-term buybacks but also supports the thesis that buybacks and dividends will be prioritized as cash generation recovers.
Catalysts (what will re-rate the stock)
- Execution on buybacks and dividend flowback. Management authorized $3 billion in repurchases - visible buyback activity and shrinking share count would move the EPS needle and market sentiment.
- Improving margins across Refined & Specialty Oils as biodiesel and renewable diesel feedstock demand grows, increasing processing spreads.
- Operational synergies and integration benefits from the Viterra acquisition crystallizing in the P&L (cost savings, better logistics utilization).
- Macro: a return to firmer global grain/soybean spreads on tighter global supplies or stronger demand from Asia/EM would boost origination margins.
- Positive surprise in free cash flow conversion - turning a negative FCF print into neutral/positive over the next 12-18 months would materially lower financing risk and justify a higher multiple.
Trade idea - actionable plan
I upgrade Bunge to Buy and recommend entering on this pullback. Below is a clear entry, stop and target along with how long I expect to hold the position and why.
| Action | Price |
|---|---|
| Entry | $108.00 |
| Stop loss | $99.00 |
| Target | $140.00 |
Horizon: long term (180 trading days). I expect this trade to play out over multiple seasonal cycles and corporate catalysts (integration, buybacks, margin recovery). The 180 trading-day horizon gives time for agricultural cycles to normalize, management initiatives to take effect, and for macro catalysts to appear.
Why these levels? The $108 entry gives a margin of safety versus recent highs ($134.87 52-week high on 06/03/2026) and respects near-term technical support (10/20/50-day SMAs are clustered in the $111-114 area). The $99 stop limits downside if commodity spreads deteriorate materially or if free-cash-generation stress forces larger-than-expected balance sheet actions. The $140 target is achievable within the horizon if EPS momentum and buybacks combine to re-rate the stock toward a mid-teens EV/EBITDA multiple on sustainably higher margins.
Risk management and position sizing
Given the company's negative free cash flow reported in the most recent snapshot (-$711M) and a debt/equity near 0.96, keep position sizing to a level that tolerates commodity-driven swings (I would not recommend >4-6% of portfolio allocation for retail investors initiating at the entry price). Monitor short-interest and intraday short-volume; days-to-cover sits around 4-5 days recently, so cover/rally risk exists on positive catalysts.
Risks and counterarguments
- Commodity-price risk: Bunge's origination and processing margins are sensitive to global grain and oilseed spreads. A sustained commodity price shock that compresses processing spreads would hurt earnings and cash flow.
- Negative free cash flow and integration risk: The company reported negative free cash flow in the snapshot (-$711M). Integration of large assets (Viterra) and potential one-time charges could weigh on near-term cash generation and execution.
- Policy and trade risk: Tariffs or trade barriers (as seen previously with Chinese tariffs on soybeans) can reroute flows and compress margins in specific origination corridors, creating localized losses or increased working-capital volatility.
- Weather and supply shocks: Agriculture is exposed to weather risk. A major crop beat or unexpected bumper harvest could flood markets and depress prices, while weather-driven crop losses could raise input costs for downstream customers and disrupt volumes.
- Counterargument: One could reasonably argue that Bunge is still a cyclical operator in a low-margin, high-working-capital business and that the company's negative free cash flow and near-term guidance miss (fiscal 2026 adjusted guidance $7.50-$8 vs analyst expectation $8.71) justify a lower multiple until cash conversion is proven. That view supports waiting for materially positive FCF prints before adding size.
What would change my mind
I would re-evaluate the buy thesis if any of the following occur: (1) sustained negative free cash flow beyond the next two quarters without a credible plan to restore conversion, (2) a material adverse event tied to Viterra integration or large impairment charges that materially dilute shareholder value, (3) a major policy shock (large tariffs or export restrictions) that permanently reroutes global flows and shrinks Bunge's core margin capture, or (4) a clear failure to execute the announced capital-return plan (no buybacks despite authorization and no dividend stability).
Bottom line
Bunge is an operationally strategic company in a structurally important industry. The current pullback creates a buying window where the valuation already factors in short-term softness, but the long-term tailwinds - growing protein demand, renewable feedstock needs, and an active capital-return program - support upside. The trade is not without risk; negative FCF and cyclical exposure require disciplined sizing and a hard stop. For those comfortable with commodity cycles, the $108 entry with a $99 stop and a $140 target over a 180-trading-day horizon offers asymmetric upside with defined downside control.
Note: keep an eye on quarterly cash flow prints and buyback activity as the primary confirmatory signals that this upgrade was timely.